Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate is a synthetic purine nucleoside diphosphate analog, structurally related to adenosine diphosphate (ADP) but with the hydroxyl group at the 3' position of the ribose replaced by an amino group and lacking an oxygen atom at that position. It belongs to the class of organic compounds known as purine 3’-deoxyribonucleoside diphosphates. This compound is primarily used in research settings as a biochemical tool or substrate analog for studying nucleotide metabolism, enzyme specificity, and structure–activity relationships in nucleic acid biochemistry. There are no approved therapeutic indications or clinical uses for this molecule[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate.